Q1 FY 2027 saw record revenue and profit growth, driven by strong performance across chemicals, fluorochemicals, and performance films, with margins boosted by supply disruptions and value-added products. Strategic investments and innovation position the company for continued growth despite ongoing global volatility.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.